A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : LST / late stent thrombosis

[Related PubMed/MEDLINE]
Total Number of Papers: 50
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   LST  (>> Co-occurring Abbreviation)
Long Form:   late stent thrombosis
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2017 Evaluation of promoting effect of a novel Cu-bearing metal stent on endothelialization process from in vitro and in vivo studies. BMS, DES, HUVECs, ISR
2017 Safety and efficacy of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent. AGF-BP-SES, CAD, DES, PK
2016 Temporal Trends in Strut-Level Optical Coherence Tomography Evaluation of Coronary Stent Coverage: A Systematic Review and Meta-Analysis. BMS, DES, OCT
2015 Histopathology of vascular response to drug-eluting stents: an insight from human autopsy into daily practice. BMS, DES, PCI
2015 Polymer-free versus permanent polymer drug eluting stents in coronary artery disease: A meta-analysis of 10 RCTs with 6575 patients. EMBASE, LLL, MI, PF-DES, PP-DES, TLR, WMD
2014 Biodegradable versus durable polymer drug eluting stents in coronary artery disease: insights from a meta-analysis of 5,834 patients. BP-DES, CAD, DP-DES, LLL, MI, TLR, WMD
2014 Comparison of long-term outcome after percutaneous coronary intervention for stent thrombosis between early, late, and very late stent thrombosis. BMS, DES, EST, MACE, TLR, VLST
2014 Macro- and microscale variables regulate stent haemodynamics, fibrin deposition and thrombomodulin expression. TM
2014 Meta-analysis of bioabsorbable versus durable polymer drug-eluting stents in 20,005 patients with coronary artery disease: an update. BP-DES, DP-DES, LLL, MI, TLR, TVR
10  2013 Fabrication of a novel polymer-free nanostructured drug-eluting coating for cardiovascular stents. CAD, CNTs, DES, EPD, MMSNs
11  2013 Late and very late stent thrombosis in patients with second-generation drug-eluting stents. DAPT, DES, EES, IQR, VLST, ZES
12  2012 An optical coherence tomography study of two new generation stents with biodegradable polymer carrier, eluting paclitaxel vs. biolimus-A9. DE, DES, OCT, PES
13  2012 Atorvastatin accelerates both neointimal coverage and re-endothelialization after sirolimus-eluting stent implantation in a porcine model: new findings from optical coherence tomography and pathology. BMS, EPCs, OCT, SEM, SES
14  2012 Complete disappearance of red thrombi in a drug-eluting stent despite discontinuation of antiplatelet therapy: Angioscopic confirmation. DES, LCX
15  2012 Examination of the in vivo mechanisms of late drug-eluting stent thrombosis: findings from optical coherence tomography and intravascular ultrasound imaging. DES, IVUS, OCT
16  2012 Stent strut coverage of titanium-nitride-oxide coated stent compared to paclitaxel-eluting stent in acute myocardial infarction: TITAX-OCT study. BAS, DES, NIH, OCT, PES
17  2011 A newly formed and ruptured atheromatous plaque within neointima after drug-eluting stent implantation: 2-year follow-up intravascular ultrasound and optical coherence tomography studies. DES
18  2011 Assessment by optical coherence tomography of stent struts across side branch. -Comparison of bare-metal stents and drug-elution stents.-. DES, OCT, SES
19  2011 Coronary responses and differential mechanisms of late stent thrombosis attributed to first-generation sirolimus- and paclitaxel-eluting stents. DES, PES, SES
20  2011 Local persistent hypercoagulability after sirolimus-eluting stent implantation in patients with stable angina. CS, LAD, SES
21  2011 Optical coherence tomography endpoints in stent clinical investigations: strut coverage. DES, OCT, VLST
22  2011 Recent advances in coronary angioscopy. DES
23  2011 Stent thrombosis of drug eluting stent: pathological perspective. BMS, DES
24  2010 A history of late and very late stent thrombosis is not associated with increased activation of the contact system, a case control study. C1-inhibitor, ELISA, FXII, FXIIa, VLST
25  2010 Angioscopic Evaluation of Neointimal Coverage of Coronary Stents. DES
26  2010 Comparison of the incidence of late stent thrombosis after implantation of different drug-eluting stents in the real world coronary heart disease patients: three-year follow-up results. ARC, CHD, DES
27  2010 Drug-eluting Stents in Acute Coronary Syndrome: Is There a Risk of Stent Thrombosis with Second-Generation Stents? BMS, DES, FDA, PCI, ST, STEMI
28  2010 In-stent thrombosis after 68 months of implantation inspite of continuous dual antiplatelet therapy: a case report. DES
29  2010 Late coronary stent thrombosis. ---
30  2010 Long-term health outcome and mortality evaluation after invasive coronary treatment using drug eluting stents with or without the IVUS guidance. Randomized control trial. HOME DES IVUS. ARC, DES, IVUS, MACEs
31  2010 Pathobiology of stent thrombosis after drug-eluting stent implantation. DES
32  2009 Cost-effectiveness of drug-eluting stents including the economic impact of late stent thrombosis. DES
33  2009 Late stent thrombosis, endothelialisation and drug-eluting stents. BMS, DES
34  2009 Passive and active polymer coatings for intracoronary stents: novel devices to promote arterial healing. DES, ISR, PCI
35  2008 Angioscopic findings of delayed healing at sites of sirolimus-eluting stent overlap after 21-month implantation. ---
36  2008 Antiplatelet therapy following drug-eluting stent implantation: new clinical data and recommendations. BMS, DES, PCI, ST
37  2008 Meta-analysis shows similar risk of thrombosis after drug-eluting stent, bare-metal stent, or angioplasty. BMSs, CI, DESs, OR, SAT
38  2008 Pathophysiology of vascular healing and stent mediated arterial injury. DES
39  2008 The paradigm of endothelium and stent thrombosis in DES. DES
40  2007 Analysis of 36 reported cases of late thrombosis in drug-eluting stents placed in coronary arteries. DESs
41  2007 Emergency percutaneous coronary intervention (PCI) for the care of patients with ST-elevation myocardial infarction (STEMI). ACS, BMS, CCL, DES, ER, IC, IVUS, PCI, STEMI
42  2007 Late loss of early benefit from drug-eluting stents when compared with bare-metal stents and coronary artery bypass surgery: 3 years follow-up of the ERACI III registry. BMS, CABG, CVD, DES, MACCE
43  2007 Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. ---
44  2007 Predictors of target lesion revascularization and documented stent thrombosis beyond 30 days after sirolimus-eluting stent implantation: retrospective analysis in consecutive 1,070 angiographic follow-up lesions. ISR, SES, TLR, VLST
45  2007 Stent undersizing can result in procedure-related very late stent thrombosis. ---
46  2007 [Clinical features of late stent thrombosis after successful sirolimus-eluting stent implantation]. SES
47  2006 Late complications following the deployment of drug eluting stents. DES
48  2006 Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. BMS, DES
49  2006 Very late bare-metal stent thrombosis. A case report and review of the literature. VLST
50  2003 Pathological mechanisms of fatal late coronary stent thrombosis in humans. ---